Fundus Autofluorescence Imaging in Age-Related Macular Degeneration and Geographic Atrophy

Chapter
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 664)

Abstract

The traditional method for documenting and quantifying geographic atrophy (GA) is color photography. This method has been shown to be reproducible in several clinical trials, including the Age-related Eye Disease Study (AREDS) and the natural progression of GA studies by Sunness et al. (AREDS No. 6, Am J Ophthalmol 132(5):668–681, 2001; Sunness et al., Invest Ophthalmol Vis Sci 40(8):1761–1769, 1999). Nevertheless, it can be difficult to distinguish between dead/nonfunctioning retinal pigment epithelium (RPE), living but depigmented RPE (RPE often release melanin granules upon injury), and yellowish coloration caused by large drusen or calcified regressed drusen. Two imaging technologies that seem promising are fundus autofluorescence (FAF) and spectral domain (high resolution) optical coherence tomography (SDOCT). Here we provide an overview of FAF imaging in the setting of age-related macular degeneration (AMD) and GA.

Keywords

Placebo Filtration Retina Coherence Stratification 

References

  1. Age-Related Eye Disease Study (AREDS) Research Group (2001) The age-related eye disease study system for classifying age-related macular degeneration from stereoscopic color fundus photographs: AREDS report No. 6. Am J Ophthalmol 132(5):668–681CrossRefGoogle Scholar
  2. Bindewald A, Schmitz-Valkenberg S, Jorzik JJ et al (2005) Classification of abnormal fundus autofluorescence patterns in the junctional zone of geographic atrophy in patients with age related macular degeneration. Br J Ophthalmol 89(7):874–878CrossRefPubMedGoogle Scholar
  3. Delori FC, Dorey CK, Staurenghi G et al (1995) In vivo fluorescence of the ocular fundus exhibits retinal pigment epithelium lipofuscin characteristics. Invest Ophthalmol Vis Sci 36(3):718–729PubMedGoogle Scholar
  4. Delori FC, Goger DG, Dorey CK (2001) Age-related accumulation and spatial distribution of lipofuscin in the RPE of normal subjects. Invest Ophthalmol Vis Sci 42(8):1855–1866PubMedGoogle Scholar
  5. Einbock W, Moessner A, Schnurrbusch UE et al (2005) Changes in fundus autofluorescence in patients with age-related maculopathy. Correlation to visual function: a prospective study. Graefes Arch Clin Exp Ophthalmol 243(4):300–305CrossRefPubMedGoogle Scholar
  6. Friedman DS, O’Colmain BJ, Munoz B et al (2004) Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol 122(4):564–572CrossRefPubMedGoogle Scholar
  7. Holz FG, Bellman C, Staudt S et al (2001) Fundus autofluorescence and development of geographic atrophy in age-related macular degeneration. Invest Ophthalmol Vis Sci 42(5):1051–1056PubMedGoogle Scholar
  8. Holz FG, Bindewald-Wittich A, Fleckenstein M et al (2007) Progression of geographic atrophy and impact of fundus autofluorescence patterns in age-related macular degeneration. Am J Ophthalmol 143(3):463–472CrossRefPubMedGoogle Scholar
  9. Klein R, Klein BE, Jensen SC et al (1997) The five-year incidence and progression of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology 104(1):7–21PubMedGoogle Scholar
  10. Lois N, Owens SL, Coco R et al (2002) Fundus autofluorescence in patients with age-related macular degeneration and high risk of visual loss. Am J Ophthalmol 133(3):341–349CrossRefPubMedGoogle Scholar
  11. Radu RA, Han Y, Bui TV et al (2005) Reductions in serum vitamin A arrest accumulation of toxic retinal fluorophores: a potential therapy for treatment of lipofuscin-based retinal diseases. Invest Ophthalmol Vis Sci 46(12):4393–4401CrossRefPubMedGoogle Scholar
  12. Schmitz-Valckenberg S, Bultmann S, Dreyhaupt J et al (2004) Fundus autofluorescence and fundus perimetry in the junctional zone of geographic atrophy in patients with age-related macular degeneration. Invest Ophthalmol Vis Sci 45(12):4470–4476CrossRefPubMedGoogle Scholar
  13. Scholl HP, Bellmann C, Dandekar SS et al (2004) Photopic and scotopic fine matrix mapping of retinal areas of increased fundus autofluorescence in patients with age-related maculopathy. Invest Ophthalmol Vis Sci 45(2):574–583CrossRefPubMedGoogle Scholar
  14. Shaumberg DA, Hankinson SE, Guo Q et al (2007) A prospective study of 2 major age-related macular degeneration susceptibility alleles and interaction with modifiable risk factors. Arch Ophthalmol 125(1):55–62CrossRefGoogle Scholar
  15. Sieving PA, Caruso RC, Tao W et al (2006) Ciliary neurotrophic factor (CNTF) for human retinal degeneration: phase I trial of CNTF delivered by encapsulated cell intraocular implants. Proc Natl Acad Sci USA 103(10):3896–3901CrossRefPubMedGoogle Scholar
  16. Sparrow JR, Fishkin N, Zhou J et al (2003) A2E, a byproduct of the visual cycle. Vision Res 43(28):2983–2990CrossRefPubMedGoogle Scholar
  17. Sunness JS, Bressler NM, Tian Y et al (1999) Measuring geographic atrophy in advanced age-related macular degeneration. Invest Ophthalmol Vis Sci 40(8):1761–1769PubMedGoogle Scholar
  18. Sunness JS, Margalit E, Srikumaran D et al (2007) The long-term natural history of geographic atrophy from age-related macular degeneration: enlargement of atrophy and implications for interventional trials. Ophthalmology 114(2):271–277CrossRefPubMedGoogle Scholar
  19. Wang M, Lam TT, Fu J et al (1995) TEMPOL, a superoxide dismutase mimic, ameliorates light-induced retinal degeneration. Res Commun Mol Pathol Pharmacol 89(3):291–305PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  1. 1.The Duke Center for Macular Diseases, Duke Eye CenterDurhamUSA
  2. 2.The Duke Center for Macular Diseases and Albert Eye Research InstituteDuke University Eye CenterDurhamUSA
  3. 3.Department of OphthalmologyDuke UniversityDurhamUSA

Personalised recommendations